Pharmacological inhibition of kinases was chosen over siRNA knockdown as the latter is still quite inefficient in primary CD4+ cells and certain barriers to infection in primary cells—such as cortical actin—are not present in cell lines [26]. The gene discussed is CD4; the disease is infection.